Clinical Trials
2 trialsNCT00110188 2015-11-20
Ridaforolimus (AP23573/MK-8669) in Participants With Taxane-Resistant Androgen-Independent Prostate Cancer (AIPC)(MK-8669-017)
Merck Sharp & Dohme LLC
Phase 2 Completed
NCT00777959 2015-08-19
Bicalutamide and Ridaforolimus in Men With Prostate Cancer (MK-8669-002)
Merck Sharp & Dohme LLC
Phase 2 Completed